Explore

Trendline Trendline
CRISPR Therapeutics Reports Progress in Gene-Edited Therapies

CRISPR Therapeutics Reports Progress in Gene-Edited Therapies

CRISPR Therapeutics Reports Progress in Gene-Edited Therapies
Trendline Trendline
Merck Reports Q2 2026 Financial Results, Highlights Key Drug Approvals

Merck Reports Q2 2026 Financial Results, Highlights Key Drug Approvals

Merck Reports Q2 2026 Financial Results, Highlights Key Drug Approvals
Trendline Trendline
Alpha Cognition to Announce Q2 2026 Financial Results and Business Update

Alpha Cognition to Announce Q2 2026 Financial Results and Business Update

Alpha Cognition to Announce Q2 2026 Financial Results and Business Update
Trendline Trendline
Billionaire Stanley Druckenmiller's Investment in Revolution Medicines Yields Significant Returns

Billionaire Stanley Druckenmiller's Investment in Revolution Medicines Yields Significant Returns

Billionaire Stanley Druckenmiller's Investment in Revolution Medicines Yields Significant Returns
Trendline Trendline
Pfizer's Q2 2026 Earnings Highlight COVID's Impact on Revenue Guidance

Pfizer's Q2 2026 Earnings Highlight COVID's Impact on Revenue Guidance

Pfizer's Q2 2026 Earnings Highlight COVID's Impact on Revenue Guidance
Rapid Read Rapid Read
CRISPR Medicine News and Chinese Society of Gene Cell Therapy Form Partnership to Enhance Global Collaboration

CRISPR Medicine News and Chinese Society of Gene Cell Therapy Form Partnership to Enhance Global Collaboration

CRISPR Medicine News (CMN) and the Chinese Society of Gene & Cell Therapy (CSGCT) have announced a media partnership aimed at strengthening international scientific communication and collaboration in the field of CRISPR, gene, and cell therapy. This partnership will facilitate joint content initiatives, expert interviews, trial reports, and international discussions. CMN will expand its coverage of scientific developments from China, while CSGCT will promote CMN's content within its community. The collaboration will also include co-hosting events and educational activities to foster dialogue among researchers, clinicians, and industry leaders. The partnership underscores a commitment to advancing international collaboration and supporting responsible innovation in CRISPR and gene therapy.
Trendline Trendline
Moderna Reports Q2 2026 Earnings: Revenue Growth and Pipeline Expansion Amid Challenges

Moderna Reports Q2 2026 Earnings: Revenue Growth and Pipeline Expansion Amid Challenges

Moderna Reports Q2 2026 Earnings: Revenue Growth and Pipeline Expansion Amid Challenges
Trendline Trendline
Novo Nordisk Faces Setback as Heart Drug Trial Fails to Meet Key Endpoint

Novo Nordisk Faces Setback as Heart Drug Trial Fails to Meet Key Endpoint

Novo Nordisk Faces Setback as Heart Drug Trial Fails to Meet Key Endpoint
Rapid Read Rapid Read
Chinese Gene Therapy Trial Raises Concerns After Child's Death

Chinese Gene Therapy Trial Raises Concerns After Child's Death

A six-year-old girl named Mei from China tragically passed away following an experimental gene therapy aimed at treating Snijders Blok-Campeau syndrome, a rare neurodevelopmental disorder. The therapy, developed by neuroscientist Zilong Qiu at Shanghai Jiao Tong University, involved using CRISPR-based techniques to correct a genetic mutation directly in Mei's brain cells. Despite promising results in animal trials, the therapy led to severe complications, including a high fever and kidney failure, ultimately resulting in Mei's death. Investigations revealed that prior studies had indicated potential risks, such as severe liver damage and immune complications, which were not adequately addressed before the trial proceeded.
Trendline Trendline
Moderna Maintains Growth Target Despite Norovirus Vaccine Setback

Moderna Maintains Growth Target Despite Norovirus Vaccine Setback

Moderna Maintains Growth Target Despite Norovirus Vaccine Setback
Trendline Trendline
FDA Advisory Committee Supports Replimune's Melanoma Drug Amid Data Concerns

FDA Advisory Committee Supports Replimune's Melanoma Drug Amid Data Concerns

FDA Advisory Committee Supports Replimune's Melanoma Drug Amid Data Concerns
Trendline Trendline
UniQure Prepares for Potential FDA Advisory Committee Meeting on Huntington's Gene Therapy Amid Regulatory Uncertainty

UniQure Prepares for Potential FDA Advisory Committee Meeting on Huntington's Gene Therapy Amid Regulatory Uncertainty

UniQure Prepares for Potential FDA Advisory Committee Meeting on Huntington's Gene Therapy Amid Regulatory Uncertainty